The core function of the Screening Group (SCR) at IARC is to provide data on the accuracy, reproducibility, efficacy, benefits, harmful effects, and cost-effectiveness of various early detection interventions for breast, cervical, colorectal, and oral cancers, among others, in reducing deaths and improving patients’ quality of life in various settings. These data can then be used to inform and improve the rational use of health-care resources. The Group’s ultimate objective is to guide the development of public health policies for implementing screening in a variety of health-care settings, in particular in low- and middle-income countries (LMICs).

SCR conducts field studies in LMICs to evaluate various early detection methods for breast, cervical, colorectal, and oral cancer control. These initiatives also address the means by which screening services could be scaled up through local public health services. SCR develops various training resources to catalyse and augment capacity building in close collaboration with national institutions and government health services. Through its research programme, SCR generates scientific evidence to support the development of resource-appropriate early detection policies and health systems for the delivery of effective early services. The Cancer Screening in 5 Continents (CanScreen5) project of the Group aims to collect information on characteristics and performance of cancer screening programmes around the world and disseminate such information for informed decision making in cancer screening programmes. For example, the Group significantly contributed also to the evaluation of the safety and efficacy of less than three doses of the HPV vaccine in protecting against cervical cancer.

Visitors and news

Visit of Dr Sylla Malvi, Consultant cytologist Nargis Dutt Memorial Cancer Hospital, Barshi, India

16/09/2019 – 20/09/2019
Dr Sylla Malvi worked with the Screening Group on the development of training modules about basics of cervical cytology for the IFCPC/IARC course on colposcopy and cervical cancer prevention available online soon.

Vous êtes médecin généraliste pratiquant à Lyon et vous souhaitez mettre à jour vos connaissances sur la vaccination et les vaccins HPV ?

Nous vous proposons de participer à un atelier interactif d'une heure sans avoir à vous déplacer.
« PAPRICA »: dispositif de formation collaboratif et à distance est construit en deux temps :
  • Se préparer : durée de 10 minutes, à faire seul(e), et à n’importe quel moment avant la classe virtuelle.
  • Participer à une classe virtuelle : durée maximale d'une heure, en présence d'autres médecins participants tous connectés en même temps depuis leur cabinet (ou tout autre lieu) et d'un animateur de l'OMS.
Information et inscription : https://paprica-rhone.fr

Postdoctoral Fellowships: Le Bonniec Alice

16/09/2019 - 16/03/2021
Alice Le Bonniec, PhD in health and social psychology, has recently joined the screening group at IARC as a postdoctoral fellow. Alice will be involved in the CANelles project. This project aims to develop a social network in breast cancer screening in France to be used as a Shared Decision Making tool for both women at the age of joining the breast cancer screening programme and General Practitioners.

All visitors and news

Scientific papers

Ndizeye Z., Menon S., Van Geertruyden J.P., Sauvaget C., Jacquemyn Y., Bogers J.P., Benoy I., Vanden Broeck D. Performance of OncoE6TM Cervical Test in detecting cervical precancer lesions in HIV-positive women attending an HIV clinic in Bujumbura, Burundi: a cross-sectional study. BMJ Open. 2019 Sep 6;9(9):e029088.
PMID: 31494606
Vale D.B., Anttila A., Ponti A., Senore C., Sankaranarayanan R., Ronco G., Segnan N., Tomatis M., Žakelj M.P., Elfstrom K.M., Lonnberg S., Dillner J., Basu P. Response to the author: invitation to cancer screening: putting the car before the horse? Eur J Cancer Prev. 2019 Sep;28(5):458-459.
PMID: 31385844
Sangrajrang S., Laowahutanont P., Wongsena M., Muwonge R., Imsamran W., Ploysawang P., Basu P. Human papillomavirus (HPV) DNA and mRNA primary cervical cancer screening: Evaluation and triaging options for HPV-positive women. J Med Screen. 2019 Jul 31.
PMID: 31364471

All scientific papers

IARC, 150 Cours Albert Thomas, 69372 Lyon CEDEX 08, France - Tel: +33 (0)4 72 73 84 85 - Fax: +33 (0)4 72 73 85 75
© IARC 2019 - Terms of use  -  Privacy Policy.